Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQHU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,951
Award facts
- Contract value 100% obligated
- $18,950.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,950.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The award was issued on January 6, 2026, with an ultimate completion date of January 28, 2026, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The underlying IDC, designated contract SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and positions the contractor as a critical supplier of both branded and generic prescription medications, biologics, vaccines, and medical consumables through 2036. DLS Medical Supply Chain division manages this acquisition to ensure consistent pharmaceutical availability across the global military medical system.
Quick answers
Who was awarded contract SPE2DR26FQHU6?
SPE2DR26FQHU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FQHU6 worth?
The government has obligated $18,951 on SPE2DR26FQHU6.
Is contract SPE2DR26FQHU6 an order under another contract?
Yes. SPE2DR26FQHU6 is a delivery order under SPE2DR25D9759, an indefinite delivery contract.
Was contract SPE2DR26FQHU6 competed?
The extent of competition for SPE2DR26FQHU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award